GenSight Biologics S.A. (SIGHT.PA)

EUR 0.29

(-3.52%)

Inventory Summary of GenSight Biologics S.A.

  • GenSight Biologics S.A.'s latest annual inventory in 2023 was 1.00 EUR , down -100.0% from previous year.
  • GenSight Biologics S.A.'s latest quarterly inventory in 2024 Q1 was 1.05 Million EUR , up 105099900.0% from previous quarter.
  • GenSight Biologics S.A. reported annual inventory of 8.48 Million EUR in 2022, up 94.18% from previous year.
  • GenSight Biologics S.A. reported annual inventory of 4.36 Million EUR in 2021, up 128.69% from previous year.
  • GenSight Biologics S.A. reported quarterly inventory of 1.05 Million EUR for 2024 Q1, up 105099900.0% from previous quarter.
  • GenSight Biologics S.A. reported quarterly inventory of 1.00 EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Inventory Chart of GenSight Biologics S.A. (2023 - 2012)

Historical Annual Inventory of GenSight Biologics S.A. (2023 - 2012)

Year Inventory Inventory Growth
2023 1.00 EUR -100.0%
2022 8.48 Million EUR 94.18%
2021 4.36 Million EUR 128.69%
2020 1.91 Million EUR 599.63%
2019 273 Thousand EUR -96.91%
2018 8.84 Million EUR 883999900.0%
2017 1.00 EUR 100.0%
2016 -3.35 Million EUR -381.05%
2015 1.19 Million EUR 325.25%
2014 -530.46 Thousand EUR 0.0%
2013 - EUR 0.0%
2012 - EUR 0.0%

Peer Inventory Comparison of GenSight Biologics S.A.

Name Inventory Inventory Difference
ABIONYX Pharma SA 221 Thousand EUR 100.0%
ABIVAX Société Anonyme 1.00 EUR 0.0%
Adocia SA 272 Thousand EUR 100.0%
Aelis Farma SA 53 Thousand EUR 99.998%
Biophytis S.A. - EUR -Infinity%
Advicenne S.A. 1.74 Million EUR 100.0%
genOway Société anonyme 982.75 Thousand EUR 100.0%
IntegraGen SA 311.44 Thousand EUR 100.0%
Medesis Pharma S.A. 164.62 Thousand EUR 99.999%
Neovacs S.A. - EUR -Infinity%
NFL Biosciences SA -1.1 Million EUR 100.0%
Plant Advanced Technologies SA 1.22 Million EUR 100.0%
Quantum Genomics Société Anonyme -119.17 Thousand EUR 100.001%
Sensorion SA - EUR -Infinity%
Theranexus Société Anonyme - EUR -Infinity%
TME Pharma N.V. 91 Thousand EUR 99.999%
Valbiotis SA 1 Million EUR 100.0%
TheraVet SA 123.34 Thousand EUR 99.999%
Valerio Therapeutics Société anonyme 1.00 EUR 0.0%
argenx SE 281.12 Million EUR 100.0%
BioSenic S.A. - EUR -Infinity%
Celyad Oncology SA 1.26 Million EUR 100.0%
DBV Technologies S.A. 1.00 USD 0.0%
Galapagos NV 73.97 Million EUR 100.0%
Genfit S.A. 4000.00 EUR 99.975%
GeNeuro SA - EUR -Infinity%
Hyloris Pharmaceuticals SA 1.00 EUR 0.0%
Innate Pharma S.A. 1.00 EUR 0.0%
Inventiva S.A. 417 Thousand EUR 100.0%
MaaT Pharma SA 190 Thousand EUR 99.999%
MedinCell S.A. -6.71 Million EUR 100.0%
Nanobiotix S.A. 200 Thousand EUR 100.0%
Onward Medical N.V. 936 Thousand EUR 100.0%
Oryzon Genomics S.A. 6029.00 EUR 99.983%
OSE Immunotherapeutics SA - EUR -Infinity%
Oxurion NV 128 Thousand EUR 99.999%
Pharming Group N.V. 51.38 Million EUR 100.0%
Poxel S.A. 2.95 Million EUR 100.0%
Transgene SA - EUR -Infinity%
Financière de Tubize SA - EUR -Infinity%
UCB SA 1.03 Billion EUR 100.0%
Valneva SE 44.46 Million EUR 100.0%
Vivoryon Therapeutics N.V. 1.00 EUR 0.0%